Tiansheng Pharmaceutical Group Co. Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002QC3
CNY
4.89
0.06 (1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Tiansheng Pharmaceutical Group Co. Ltd.

Why is Tiansheng Pharmaceutical Group Co. Ltd. ?

1
Poor Management Efficiency with a low ROCE of 0%
  • The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of -15.59% and Operating profit at 12.97% over the last 5 years
3
Flat results in Mar 26
  • OPERATING CASH FLOW(Y) Lowest at CNY 12.44 MM
  • INTEREST(Q) At CNY 3.63 MM has Grown at inf%
  • OPERATING PROFIT(Q) Lowest at CNY -12.37 MM
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 6.86%, its profits have risen by 33.3%
5
Underperformed the market in the last 1 year
  • The stock has generated a return of 6.86% in the last 1 year, much lower than market (China Shanghai Composite) returns of 23.91%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tiansheng Pharmaceutical Group Co. Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Tiansheng Pharmaceutical Group Co. Ltd.
5.39%
1.32
26.81%
China Shanghai Composite
21.43%
1.73
13.79%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-15.59%
EBIT Growth (5y)
12.97%
EBIT to Interest (avg)
-8.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.23
Tax Ratio
9.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.56
EV to EBIT
-15.28
EV to EBITDA
58.27
EV to Capital Employed
0.58
EV to Sales
2.25
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.80%
ROE (Latest)
-2.77%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET PROFIT(HY)

Higher at CNY -20.13 MM

RAW MATERIAL COST(Y)

Fallen by -31.15% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 1.85 times

-6What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 12.44 MM

INTEREST(Q)

At CNY 3.63 MM has Grown at inf%

OPERATING PROFIT(Q)

Lowest at CNY -12.37 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -9.37 %

Here's what is working for Tiansheng Pharmaceutical Group Co. Ltd.

Net Profit
Higher at CNY -20.13 MM
than preceding 12 month period ended Mar 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Net Profit
At CNY -20.13 MM has Grown at 68.48%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Debtors Turnover Ratio
Highest at 1.85 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -31.15% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tiansheng Pharmaceutical Group Co. Ltd.

Interest
At CNY 3.63 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 12.44 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit
Lowest at CNY -12.37 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at -9.37 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales